For 60 years, doctors and scientists searched for a vaccine against a common virus that, while sometimes deadly, is little known to the public. The hunt is over.
May 6, 2023
0
26
British drugs giant GlaxoSmithKline on Monday demerges its newly-named consumer healthcare unit Haleon, resulting in what is set to be London's largest new stock market listing in more than a decade.
Jul 16, 2022
0
5
Scientists have identified an enzyme that is a "master regulator" of kidney function that if excessively suppressed, can trigger renal failure. Their findings have implications for the use of existing drugs and the development ...
Jan 24, 2019
0
334
The world desperately needs new antibiotics to fight infection as bacteria become resistant to existing options.
Nov 4, 2022
0
15
Scientists discovered how a gene mutation affects T cell function to promote immune disorders and then tested a treatment based on the discovery—successfully fixing donated immune cells from a 16-year-old boy with an abnormally ...
Jan 30, 2018
0
337
Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines.
Dec 19, 2018
0
8
MIT scientists have identified a potential new strategy for treating Fragile X syndrome, a disorder that is the leading heritable cause of intellectual disability and autism.
May 20, 2020
0
95
GlaxoSmithKline on Wednesday said it had agreed to buy US group Sierra Oncology, a specialist in medicines for rare forms of cancer, for $1.9 billion as the British drugs giant restructures.
Apr 13, 2022
0
2
British drugs giant GlaxoSmithKline said Tuesday that its consumer healthcare division will be spun off later this year under the name Haleon.
Feb 22, 2022
0
10
Haleon, the consumer healthcare unit spun off by British drugs giant GlaxoSmithKline, was worth around £31 billion ($36 billion) when it began trading in London on Monday.
Jul 18, 2022
0
2
